<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37157007</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Lupus anti-coagulant hypoprothrombinemia syndrome across different ages: a case report and review of the literature.</ArticleTitle><Pagination><StartPage>2231</StartPage><EndPage>2236</EndPage><MedlinePgn>2231-2236</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06619-3</ELocationID><Abstract><AbstractText>Lupus anti-coagulant hypoprothrombinemia syndrome (LAHPS) is a rare condition that can be difficult to treat. It increases the risk of thrombosis and bleeding due to the presence of lupus anti-coagulant and factor II deficiency, respectively. There are a limited number of cases described in the literature. Herein we describe a case of LAHPS with bleeding symptoms as a first clinical manifestation of systemic lupus erythematosus (SLE) in an 8-year-old female. She has had multiple recurrences of her bleeding symptoms, requiring treatment with steroids, cyclophosphamide, mycophenolate mofetil, and rituximab. Her course was later complicated by development of arthritis and lupus nephritis. Her complicated course provides a new perspective on the clinical course and treatment of LAHPS. We also present a comprehensive literature review which demonstrates the difficulty in treating patients with LAHPS with underlying SLE and the variability of the clinical course and management of LAHPS depending on the age at presentation.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chumsky</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8983-6829</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pediatric Rheumatology, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carroll</LastName><ForeName>William L</ForeName><Initials>WL</Initials><Identifier Source="ORCID">0000-0003-1550-4167</Identifier><AffiliationInfo><Affiliation>Perlmutter Cancer Center, Departments of Pediatrics and Pathology, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierce</LastName><ForeName>Kristyn A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hillier</LastName><ForeName>Kirsty</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7080-2293</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Pediatric Hematology-Oncology, Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, 160 E 32Nd St., L3 Medical, New York, NY, 10016, USA. Kirsty.hillier@nyulangone.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016682">Lupus Coagulation Inhibitor</NameOfSubstance></Chemical><Chemical><RegistryNumber>8N3DW7272P</RegistryNumber><NameOfSubstance UI="D003520">Cyclophosphamide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007020" MajorTopicYN="Y">Hypoprothrombinemias</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016682" MajorTopicYN="N">Lupus Coagulation Inhibitor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003520" MajorTopicYN="N">Cyclophosphamide</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-phospholipid syndrome</Keyword><Keyword MajorTopicYN="N">Bleeding</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">Thromboses</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37157007</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06619-3</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06619-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taddio A, Brescia AC, Lepore L, Rose&#x2019; CD (2007) Steady improvement of prothrombin levels after cyclophosphamide therapy in pediatric lupus anticoagulant hypoprothrombinemia syndrome (LAHPS). Clin Rheumatol 26(12):2167&#x2013;2169. https://doi.org/10.1007/s10067-007-0647-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-007-0647-5</ArticleId><ArticleId IdType="pubmed">17516128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara K, Shimizu J, Tsukahara H, Shimada A (2019) Lupus anticoagulant-hypoprothrombinemia syndrome and immunoglobulin-A vasculitis: a report of Japanese sibling cases and review of the literature. Rheumatol Int 39(10):1811&#x2013;1819. https://doi.org/10.1007/s00296-019-04404-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-019-04404-7</ArticleId><ArticleId IdType="pubmed">31392497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto A, Ogura M, Hattori A et al (2021) Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention. Thrombosis J 19 https://doi.org/10.1186/s12959-021-00271-0</Citation></Reference><Reference><Citation>Galli M, Barbui T (1999) Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood 93(7):2149&#x2013;2157. https://doi.org/10.1182/blood.V93.7.2149</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V93.7.2149</ArticleId><ArticleId IdType="pubmed">10090921</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, Ishiguro A, Takayanagi T, Matsui T, Tonegawa N, Maekawa T, Itabashi K (2014) A case of lupus anticoagulant hypoprothrombinemia syndrome following adenovirus gastroenteritis and mycoplasma pneumonia. Nihon Rinsho Meneki Gakkai Kaishi. 37(1):55&#x2013;60. https://doi.org/10.2177/jsci.37.55 . (Japanese)</Citation><ArticleIdList><ArticleId IdType="doi">10.2177/jsci.37.55</ArticleId><ArticleId IdType="pubmed">24598069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshika M, Komiyama Y, Yoshida M, Naito S, Ieko M, Tsuta K (2016) A case of lupus anticoagulant-hypoprothrombinemia syndrome with phosphatidylserine-dependent anti-prothrombin antibody. Rinsho Byori. 64(6):631&#x2013;635 (Japanese)</Citation><ArticleIdList><ArticleId IdType="pubmed">30695316</ArticleId></ArticleIdList></Reference><Reference><Citation>Atieh T, Lichtin A (2019) An unusual cause of bruising. Cleve Clin J Med 86(8):535&#x2013;542. https://doi.org/10.3949/ccjm.86a.18119</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.86a.18119</ArticleId><ArticleId IdType="pubmed">31385794</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama D, Hanajiri R, Kanematsu T, Ito R, Yamamoto S, Imoto N, Suzuki N, Kurahashi S, Sugiura I (2020) Lupus anticoagulant-hypoprothrombinemia syndrome associated with follicular lymphoma. Rinsho Ketsueki. 61(7):745&#x2013;749 (Japanese)</Citation><ArticleIdList><ArticleId IdType="pubmed">32759560</ArticleId></ArticleIdList></Reference><Reference><Citation>Favier R, Kheyar T, Renolleau S, Tabone MD, Favier M, Ulinski T (2012) Lupus anticoagulant-hypoprothrombinemia syndrome revealing systemic lupus in an 11-year old girl in a context of clinical and biological emergency. Ann Biol Clin (Paris) 70(2):226&#x2013;230. https://doi.org/10.1684/abc.2012.0690</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/abc.2012.0690</ArticleId><ArticleId IdType="pubmed">22484537</ArticleId></ArticleIdList></Reference><Reference><Citation>Morinaga S, Ide Y, Kusumoto M, Ogata M, Takaki K, Matsumoto E (2012) Lupus anticoagulant-hypoprothrombinemia syndrome with a false-positive test for coagulation factor inhibitors. Rinsho Ketsueki 53(7):716&#x2013;720</Citation><ArticleIdList><ArticleId IdType="pubmed">22975775</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Me L, Xue F, Liu W, Hao Y, Guan Y, Sun B, Lyu C, Gu X, Fu R, Huang Y, Liu W, Chen Y, Liu X, Zhang L, Yang R (2016) Lupus anticoagulant: two cases report and literature review. Zhonghua Xue Ye Xue Za Zhi 37(2):130&#x2013;133. https://doi.org/10.3760/cma.j.issn.0253-2727.2016.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0253-2727.2016.02.009</ArticleId><ArticleId IdType="pubmed">27014983</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JZ, Tian X, Liao CS, He XL, Zhu CG (2022) Recurrent epistaxis with coagulation disorders in a boy aged 2 years. Zhongguo Dang Dai Er Ke Za Zhi 24(7):817&#x2013;820. https://doi.org/10.7499/j.issn.1008-8830.2203060</Citation><ArticleIdList><ArticleId IdType="doi">10.7499/j.issn.1008-8830.2203060</ArticleId><ArticleId IdType="pubmed">35894199</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelsen J, Nielsen SM, Thorsen S (2006) Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome. Ugeskr Laeger 168(5):486&#x2013;487</Citation><ArticleIdList><ArticleId IdType="pubmed">16472441</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdo L, Mekinian A, Riviere S, Fain O (2016) A case of lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus. Joint Bone Spine 83(5):589&#x2013;590. https://doi.org/10.1016/j.jbspin.2015.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2015.06.016</ArticleId><ArticleId IdType="pubmed">26654379</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan EY, Leung KFS, Soo ETL, Ma ALT (2021) A Chinese boy with lupus anticoagulant-hypoprothrombinemia syndrome: a case report and review of the literature. J Pediatr Hematol Oncol 43(3):e445&#x2013;e447. https://doi.org/10.1097/MPH.0000000000001805</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPH.0000000000001805</ArticleId><ArticleId IdType="pubmed">32287097</ArticleId></ArticleIdList></Reference><Reference><Citation>Indolfi G, Poggi GM, Regoli M, Bartolini E, Nesi A, Resti M (2013) A coeliac child presenting with bleeding. Acta Paediatr 102(5):e191&#x2013;e192. https://doi.org/10.1111/apa.12171</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.12171</ArticleId><ArticleId IdType="pubmed">23350637</ArticleId></ArticleIdList></Reference><Reference><Citation>Hift RJ, Bird AR, Sarembock BD (1991) Acquired hypoprothrombinaemia and lupus anticoagulant: response to steroid therapy. Br J Rheumatol 30(4):308&#x2013;310. https://doi.org/10.1093/rheumatology/30.4.308</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/30.4.308</ArticleId><ArticleId IdType="pubmed">1907519</ArticleId></ArticleIdList></Reference><Reference><Citation>Anurathapan U, Sasanakul W, Sirachainan N, Kasemkosolsri C, Jaovisidha S, Chuansumrit A (2012) Acquired hypoprothrombinemia inducing bleeding in a girl with transient antiphospholipid antibody: case report. J Med Assoc Thai 95(2):282&#x2013;287</Citation><ArticleIdList><ArticleId IdType="pubmed">22435262</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams S, Linardic C, Wilson O, Comp P, Gralnick HR (1996) Acquired hypoprothrombinemia: effects of danazol treatment. Am J Hematol 53(4):272&#x2013;276. https://doi.org/10.1002/(SICI)1096-8652(199612)53:4%3c272::AID-AJH14%3e3.0.CO;2-E</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-8652(199612)53:4&lt;272::AID-AJH14&gt;3.0.CO;2-E</ArticleId><ArticleId IdType="pubmed">8948670</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauge L, Passeron A, Alhenc-Gelas M, Pouchot J, Darnige L (2015) Activated partial thromboplastin time sensitivity to lupus anticoagulant in a patient with transient arthritis and lupus anticoagulant-hypoprothrombinemia syndrome. Ann Hematol 94(4):713&#x2013;715. https://doi.org/10.1007/s00277-014-2245-3 . (Epub 2014 Nov 9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-014-2245-3</ArticleId><ArticleId IdType="pubmed">25380995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdel S, Baglan E, Azapa&#x11f;as&#x131; E&#xdc;, Eroglu FK, Karg&#x131;n Cak&#x131;c&#x131; E, Bulbul M (2020) An extremely rare cause of prolonged menstruation: lupus anticoagulant-hypoprothrombinemia syndrome. J Obstet Gynaecol 40(6):887&#x2013;888. https://doi.org/10.1080/01443615.2019.1637406 . (Epub 2019 Sep 3)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01443615.2019.1637406</ArticleId><ArticleId IdType="pubmed">31478416</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Huang XM (2022) Autoimmune hemolytic anemia as an initial presentation in children with systemic lupus erythematosus: two case reports. J Int Med Res. 50(8):3000605221115390. https://doi.org/10.1177/03000605221115390</Citation></Reference><Reference><Citation>Davey AL, Foxton SJ, Bala P, Richards M, Cuthbert A (2007) Bruising: when it is spontaneous and not idiopathic thrombocytopenia purpura. J Paediatr Child Health 43(4):310&#x2013;311. https://doi.org/10.1111/j.1440-1754.2007.01065.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1754.2007.01065.x</ArticleId><ArticleId IdType="pubmed">17444836</ArticleId></ArticleIdList></Reference><Reference><Citation>Baca V, Montiel G, Meill&#xf3;n L, Pizzuto J, Catal&#xe1;n T, Juan-Shum L, Nieva B (2002) Diagnosis of lupus anticoagulant in the lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Am J Hematol 71(3):200&#x2013;207. https://doi.org/10.1002/ajh.10194</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.10194</ArticleId><ArticleId IdType="pubmed">12410576</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Nedved D, Plapp FV, Cunningham MT (2018) Fatal pulmonary embolism and pulmonary hemorrhage in lupus anticoagulant hypoprothrombinemia syndrome: a case report and review of literature. Blood Coagul Fibrinolysis 29(8):708&#x2013;713. https://doi.org/10.1097/MBC.0000000000000776</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000776</ArticleId><ArticleId IdType="pubmed">30300149</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmugge M, T&#xf6;lle S, Marbet GA, Laroche P, Meili EO (2001) Gingival bleeding, epistaxis and haematoma three days after gastroenteritis: the haemorrhagic lupus anticoagulant syndrome. Eur J Pediatr 160(1):43&#x2013;46. https://doi.org/10.1007/pl00008415</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/pl00008415</ArticleId><ArticleId IdType="pubmed">11195017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernini JC, Buchanan GR, Ashcraft J (1993) Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr 123(6):937&#x2013;939. https://doi.org/10.1016/s0022-3476(05)80390-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(05)80390-7</ArticleId><ArticleId IdType="pubmed">8229526</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhard A, Sparling C, Sudbury S, Ford P, Laxer R, Silverman E (1994) Hypoprothrombinemia in childhood systemic lupus erythematosus. Semin Arthritis Rheum 24(1):12&#x2013;18. https://doi.org/10.1016/0049-0172(94)90095-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-0172(94)90095-7</ArticleId><ArticleId IdType="pubmed">7985033</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharanunni S, Ahluwalia J, Kumar N, Bose SK, Dhawan R, Malhotra P (2017) Lupus anticoagulant-hypoprothrombinemia syndrome: a rare cause of intracranial bleeding. Blood Coagul Fibrinolysis 28(5):416&#x2013;418. https://doi.org/10.1097/MBC.0000000000000615</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000615</ArticleId><ArticleId IdType="pubmed">28009646</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarker T, Roy S, Hollon W, Rajpurkar M (2015) Lupus anticoagulant acquired hypoprothrombinemia syndrome in childhood: two distinct patterns and review of the literature. Haemophilia 21(6):754&#x2013;760. https://doi.org/10.1111/hae.12669 . (Epub 2015 Apr 30)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hae.12669</ArticleId><ArticleId IdType="pubmed">25929557</ArticleId></ArticleIdList></Reference><Reference><Citation>Foord A, Baca N, Buchbinder D, Mahajerin A (2017) Lupus anticoagulant hypoprothrombinemia syndrome associated with severe thrombocytopenia in a child. Pediatr Blood Cancer. 64(6) https://doi.org/10.1002/pbc.26357</Citation></Reference><Reference><Citation>Pilania RK, Suri D, Jindal AK, Kumar N, Sharma A, Sharma P, Guleria S, Rawat A, Ahluwalia J, Singh S (2018) Lupus anticoagulant hypoprothrombinemia syndrome associated with systemic lupus erythematosus in children: report of two cases and systematic review of the literature. Rheumatol Int 38(10):1933&#x2013;1940. https://doi.org/10.1007/s00296-018-4127-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-018-4127-9</ArticleId><ArticleId IdType="pubmed">30099593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara Y, Makita M, Ishikawa T, Saeki K, Yamamoto K, Imajo K, Shima M, Ieko M (2013) Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein &#x3ba;-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody. Ann Hematol 92(4):563&#x2013;564. https://doi.org/10.1007/s00277-012-1600-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-012-1600-5</ArticleId><ArticleId IdType="pubmed">23076754</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorente-Ch&#xe1;vez A, Plascencia-F&#xe9;lix JF, Merayo-Chalico J (2021) Lupus anticoagulant-hypoprothrombinaemia syndrome: subdural haematoma as an unusual and initial manifestation. Mod Rheumatol Case Rep 5(2):306&#x2013;309. https://doi.org/10.1080/24725625.2021.1920139</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/24725625.2021.1920139</ArticleId><ArticleId IdType="pubmed">33970809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CH, Park CY (2008) Lupus anticoagulant-hypoprothrombinemia in healthy adult. Korean J Intern Med 23(3):149&#x2013;151. https://doi.org/10.3904/kjim.2008.23.3.149</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2008.23.3.149</ArticleId><ArticleId IdType="pubmed">18787368</ArticleId><ArticleId IdType="pmc">2686966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhowmick R, Agarwal I, Arumugam V, Kumar TS (2018) Lupus anticoagulant-hypoprothrombinemia syndrome. Indian J Pediatr 85(5):392&#x2013;393. https://doi.org/10.1007/s12098-017-2524-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-017-2524-9</ArticleId><ArticleId IdType="pubmed">29139061</ArticleId></ArticleIdList></Reference><Reference><Citation>Appert-Flory A, Fischer F, Amiral J, Monpoux F (2010) Lupus anticoagulant-hypoprothrombinemia syndrome (HLAS): report of one case in a familial infectious context. Thromb Res 126(2):e139&#x2013;e140. https://doi.org/10.1016/j.thromres.2009.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2009.11.025</ArticleId><ArticleId IdType="pubmed">20006899</ArticleId></ArticleIdList></Reference><Reference><Citation>Komvilaisak P, Wisanuyotin S, Jettrisuparb A, Wiangnon S (2017) Lupus anticoagulant-hypoprothrombinemia syndrome (LAC-HPS) in children with systemic lupus erythematosus: report of 3 cases. J Pediatr Hematol Oncol 39(8):e521&#x2013;e524. https://doi.org/10.1097/MPH.0000000000000891</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPH.0000000000000891</ArticleId><ArticleId IdType="pubmed">28787393</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkan D, Bateman H, Lockshin MD (1999) Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature. Lupus 8(7):560&#x2013;564. https://doi.org/10.1191/096120399678840846</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120399678840846</ArticleId><ArticleId IdType="pubmed">10483036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bel Feki N, Zayet S, Ben Ghorbel I, Houman MH (2016) Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage. J Mal Vasc 41(6):403&#x2013;406. https://doi.org/10.1016/j.jmv.2016.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmv.2016.07.003</ArticleId><ArticleId IdType="pubmed">27743753</ArticleId></ArticleIdList></Reference><Reference><Citation>Knobe K, Tedg&#xe5;rd U, Ek T, Sandstr&#xf6;m PE, Hillarp A (2012) Lupus anticoagulants in two children&#x2014;bleeding due to nonphospholipid-dependent antiprothrombin antibodies. Eur J Pediatr 171(9):1383&#x2013;1387. https://doi.org/10.1007/s00431-012-1737-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-012-1737-1</ArticleId><ArticleId IdType="pubmed">22527568</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocheril AP, Vettiyil GI, George AS, Shah S, Geevar T, Dave RG, T SK. (2021) Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome&#x2014;a case series with review of literature. Lupus 30(4):641&#x2013;648. https://doi.org/10.1177/0961203321988934</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203321988934</ArticleId><ArticleId IdType="pubmed">33509039</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Zehnder JL (2016) Prozone effect in the diagnosis of lupus anticoagulant for the lupus anticoagulant-hypoprothrombinemia syndrome. Am J Clin Pathol 146(2):262&#x2013;267. https://doi.org/10.1093/ajcp/aqw106</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqw106</ArticleId><ArticleId IdType="pubmed">27473743</ArticleId></ArticleIdList></Reference><Reference><Citation>Paschal RD, Neff AT (2013) Resolution of hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) after multidrug therapy with rituximab: a case report and review of the literature. Haemophilia 19(2):e62&#x2013;e65. https://doi.org/10.1111/hae.12027</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hae.12027</ArticleId><ArticleId IdType="pubmed">22989209</ArticleId></ArticleIdList></Reference><Reference><Citation>Cetin Gedik K, Siddique S, Aguiar CL (2018) Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome &#x2014; report of three cases and review of the literature. Lupus 27(7):1190&#x2013;1197. https://doi.org/10.1177/0961203317751853</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317751853</ArticleId><ArticleId IdType="pubmed">29320972</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivaldi P, Rossetti G, Galli M, Finazzi G (1997) Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica. 82(3):345&#x2013;7</Citation><ArticleIdList><ArticleId IdType="pubmed">9234588</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MT, Nardi MA, Hadzi-Nesic J, Karpatkin M (1996) Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature. Am J Hematol 51(4):307&#x2013;314. https://doi.org/10.1002/(SICI)1096-8652(199604)51:4%3c307::AID-AJH10%3e3.0.CO;2-B</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-8652(199604)51:4&lt;307::AID-AJH10&gt;3.0.CO;2-B</ArticleId><ArticleId IdType="pubmed">8602632</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeger U, Kapiotis S, Pabinger I, Puchhammer E, Kyrle PA, Lechner K (1993) Transient lupus anticoagulant associated with hypoprothrombinemia and factor XII deficiency following adenovirus infection. Ann Hematol 67(2):95&#x2013;99. https://doi.org/10.1007/BF01788133</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01788133</ArticleId><ArticleId IdType="pubmed">8394145</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphries JE, Acker MN, Pinkston JE, Ruddy S (1994) Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl. Am J Pediatr Hematol Oncol 16(4):372&#x2013;376</Citation><ArticleIdList><ArticleId IdType="pubmed">7978060</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>